Revvity Inc RVTY
News
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
Revvity to Present at Upcoming Investor Conferences
Revvity Announces Financial Results for the Second Quarter of 2026
Revvity Board Declares Quarterly Dividend
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
Revvity to Hold Earnings Call on Tuesday, August 4, 2026